Former AveXis CSO Brian Kaspar, in a previous statement from law firm Heuston Hannigan, “categorically denies any wrongdoing,” and said he is “prepared to assert his rights and defend his conduct accordingly.” And contradicting AveXis’ description, he sai
Novartis, which last week was publicly shamed by the FDA for manipulating data tied to the application of its gene therapy Zolgensma, has said that it launched an investigation in March, as soon as it learned of the issue.
Novartis caught plenty of flack with last week’s revelation that its FDA application for gene therapy Zolgensma contained manipulated data and that the company didn't inform regulators until after its approval. Now it's facing a congressional investigatio